3.Nocardia Farcinica Infectionafter Total Knee Arthroplasty:a Case Report
Xi WANG ; Jinrong CANG ; Zongzhi LIU ; Jianbing MA ; Yong LI ; Liang DUAN
Journal of Modern Laboratory Medicine 2015;(3):115-117
Infection is a catastrophiccomplication in total knee arthroplasty.Reported a case of Nocardiafarcinica infection which appeared after application of cemented total knee replacement.A 64-year-old male patient was admitted to hospital 1 months after knee surgery,with a 2-week history of pain,swelling,and restricted mobility.As no improvement could be a-chieved after synovectomy and antibiotherapy,the prosthesis were removed from him.Although improvement could not be a-chieved in the knee of the patient at the end of 10-month therapy,the case has still being followed-up.
4.Expression of monocyte chemotactic protein-1 and its receptor in sudden coronary death.
Yuan-yuan KUANG ; Xia-xia CHEN ; Cang-cheng WANG ; Kun YE ; Ying WANG ; Yong-hua SHI
Journal of Forensic Medicine 2014;30(6):413-418
OBJECTIVE:
To investigate the expression of monocyte chemotactic protein-1 (MCP-1) and its receptor CC chemokine receptor-2 (CCR-2) in coronary atherosclerosis plaques between sidden coronary death (SCD) and non-SCD. Methods The expression levels of MCP-1 and CCR-2 in SCD group, coronary atherosclerosis group (non-SCD), control group (normal coronary artery) were detected by immunohistochemistry.
RESULTS:
Positive rates of MCP-1 among the three groups were 78%, 47%, and 0%, respectively, with significant expressing differences between each two groups (P<0.05). Positive rates of CCR-2 among three groups were 72%, 47%, and 0%, respectively, with significant expressing differences between the SCD group and coronary atherosclerosis group as well as between the SCD group and control group (P<0.05), but with no significant expressing difference between coronary atherosclerosis group and control group (P>0.05).
CONCLUSION
Overexpression of MCP-1 and CCR-2 in coronary atherosclerotic plaques is closely correlated with SCD.
Chemokine CCL2/metabolism*
;
Coronary Artery Disease/pathology*
;
Death, Sudden, Cardiac/pathology*
;
Humans
;
Immunohistochemistry
;
Receptors, CCR2/metabolism*
5.ERK1/2 pathway involved in the expression of ETB receptors of the culturing smooth muscle cells of rat mesenteric artery.
Guo-gang LUO ; Yong-xiao CAO ; Cang-bao XU ; Ai-qun MA ; Lars EDVINSSON
Acta Pharmaceutica Sinica 2006;41(3):257-262
AIMTo determine the involvement of extracellular signal-regulated kinase 1/2 (ERK1/2) pathway in the expression of endothelin receptor type B (ETB) during culture.
METHODSSB386023, a specific inhibitor for ERK1/2 pathway, was used to define the intracellular signaling pathway for the upregulation of ETB receptors and sarafotoxin 6c (S6c), a selective agonist for ETB receptors, induced contraction in isolated rat superior mesenteric arteries. The contraction was recorded by a sensitive in vitro myograph and the receptor mRNA was quantified by a real-time PCR. The phosphorylated ERK1/2 proteins were analyzed by phosphoELISA assay.
RESULTSS6c induced strong contractile responses of the artery after culture for 24 h, while there was no response to S6c in fresh vessel segments. The enhanced contractile response to S6c paralleled with an increase of mRNA for ETB receptors. The phosphorylated ERK1/2 proteins significantly increased after culture for 3 h. After co-culture with SB386023 for 24 h, S6c-induced contractions significantly decreased with reduction of Emax from (217 +/- 14) % to (127 +/- 23) % (P <0.01). This response paralleled with a decreased level of ETB receptor mRNA.
CONCLUSIONERK1/2 pathway was involved in the up-regulation of ETB receptors on smooth muscle cells isolated from rat mesenteric arteries during culture.
Animals ; Cells, Cultured ; Male ; Mesenteric Arteries ; cytology ; Mitogen-Activated Protein Kinase 1 ; antagonists & inhibitors ; metabolism ; Mitogen-Activated Protein Kinase 3 ; antagonists & inhibitors ; metabolism ; Muscle Contraction ; drug effects ; Muscle, Smooth, Vascular ; cytology ; metabolism ; Organ Culture Techniques ; Phosphorylation ; RNA, Messenger ; biosynthesis ; genetics ; Rats ; Rats, Sprague-Dawley ; Receptor, Endothelin B ; biosynthesis ; genetics ; Signal Transduction ; Up-Regulation ; Vasoconstrictor Agents ; pharmacology ; Viper Venoms ; pharmacology
6.Expression of Recombinant sPDGFR?-Fc in CHO and Its Anti-proliferation Analysis
Yan WAN ; Li-Ling LI ; Qiu-Ling XIE ; Shu-Jun GUO ; Li QIN ; Yong-Cang ZHANG ; Xiao-Jia CHEN ;
China Biotechnology 2006;0(07):-
Orjective:To obtain recombinant CHO-K1 with expressing sPDGFR? and to identify the biological activities of sPDGFR? secreted in non-serum medium.Methods:Recombinant human sPDGFR? expression vector pIRES-Neo3-sPDGFR?-Fc was constructed and then transfected into CHO-K1 cells by using LipofectamineTM 2000.After screened with G418 in 8 weeks,some monoclone cells were selected randomly to amplify in 96-well-plate to 24-well-plates,and then to identify positive cell clones by RT-PCR.Furthermore,the candidate cell clones were test by Real-Time PCR and Western blot assays.Finally,anti-proliferation activities of the expressed sPDGFR? were analyzed by MTT.Results:sPDGFR?-Fc was cloned into pIRES-Neo3 correctly.The sPDGFR?-Fc expression level in recombinant CHO-K1 cell clones were concordant in between Realtime PCR and Western blot assay.sPDGFR?-Fc obtained from cultured non-serum medium of positive CHO-K1 could significantly inhibit proliferation of vascular endothelial cell.Conclusion:Successed to select recombinant CHO-K1 cell lines with high expressed sPDGFR?-Fc.The sPDGFR?-Fc can inhibit the cell proliferation significantly and it means sPDGFR?-Fc might be a new anti-cancer drug in the future.
7.Clinical Evaluation of Congenital Heart Disease in Down Syndrome.
Sang Kyu PARK ; Young Hoon KIM ; Son Moon SHIN ; Chung Il NOH ; Jung Yun CHOI ; Yong Soo YUN ; Cang Yee HONG ; Kyoo Wan CHOI ; Shin Yong MOON
Journal of the Korean Pediatric Society 1986;29(10):47-55
No abstract available.
Down Syndrome*
;
Heart Defects, Congenital*
8.Surgical treatment of Supravalvular Aortic Stenosis.
Woo Ik CANG ; Sam Se OH ; Jeong Ryul LEE ; Yong Jin KIM ; Joon Rhyang RHO ; Kyung Phill SUH
The Korean Journal of Thoracic and Cardiovascular Surgery 1998;31(8):763-769
BACKGROUND: Supravalvular aortic stenosis is a rare form of congenital cardiac anomaly involving ascending aorta distal to coronary orifice. MATERIALS AND METHODS: We operated 12 cases of supravalvular aortic stenosis between July 1986 and March 1997. Age ranged from 4 to 17 (mean 10.2) years and 11 of them were male. Nine patients had clinical features of Williams syndrome. We experienced two types of supravalvular aortic stenosis, including 10 hour glass type and 2 diffuse type. RESULTS: Preoperative transaortic pressure gradient ranged from 40 to 180 (mean 92) mmHg by cardiac catheterization. Pulmonary stenosis was associated in 5 and 2 of them required angioplasty. Operative techniques included 6 standard aortoplasty with elliptical patch, 4 extended aortoplasty with inverted Y shaped patch, and 2 modified Brom's repair. There were no operative deaths. Postoperative echocardiographic evaluation was done at a mean interval of 12 months. Grade I or II aortic regurgitation was found in 3 cases. Postoperative cardiac catheterization revealed a mean transaortic pressure gradient of 26 (range 0 to 75) mmHg. A mean pressure drop was 78 (range 30 to 114) mmHg. All patients were followed up for a mean of 40 (range 1 to 67) months with uneventful clinical course. CONCLUSIONS: Our data proved the low mortality and excellent hemodynamic improvement after surgical relief of supravalvular aortic stenosis in children.
Angioplasty
;
Aorta
;
Aortic Stenosis, Supravalvular*
;
Aortic Valve Insufficiency
;
Aortic Valve Stenosis
;
Cardiac Catheterization
;
Cardiac Catheters
;
Child
;
Echocardiography
;
Glass
;
Hemodynamics
;
Humans
;
Male
;
Mortality
;
Pulmonary Valve Stenosis
;
Williams Syndrome
9.Human enterovirus 71 that firstly isolated in Qinghai Province and their genetic features of VP1 region.
Sheng-Cang ZHAO ; Shuang-Ying JIANG ; Gui-Xiang LIU ; Hu YI ; Yong ZHANG
Chinese Journal of Experimental and Clinical Virology 2010;24(6):436-438
OBJECTIVETo study the genetic characterizations of VP1 gene of human enterovirus 71 (HEV71) isolated from clinical specimens of Hand, Foot and Mouth Disease (HFMD) patients in Qinghai Province in 2008.
METHODS335 clinical samples including stools, throat swabs and vesicle fluids were collected from HFMD patients in Qinghai Province. Viral isolation was performed, and molecular typing was performed with the positive isolates. Then 30 identified HEV71 isolates were performed for entire VP1 coding region amplification and sequencing.
RESULTSAmong the 355 clinical samples, 45 human enteroviruses were isolated, and among them, 30 were identified as HEV71. Then 30 HEV71 positive isolates were performed by nucleotide sequencing. It showed that there was some difference in the nucleotide and the amino acid among the 30 HEV71 strains, the homology were 95.2%-100% and 96.6%-100%, respectively. But they all closed to HEV71 strains isolated in China after 1998, and from the phylogenetic tree constructed with 30 Qinghai HEV71 strains and other 35 HEV71 strains represented all known genotype and subgenotype HEV71 strains available from GenBank, it revealed that the 30 Qinghai HEV71 strains clustered within the C4a evolution branch of C4 subgenotype.
CONCLUSIONHEV71 was isolated in HFMD patients in Qinghai province, and the HEV71 strains causing HFMD outbreaks in Qinghai province in 2008 were all belong to C4a evolution branch of C4 subgenotype with several transmission chains.
China ; Enterovirus A, Human ; genetics ; isolation & purification ; Hand, Foot and Mouth Disease ; virology ; Humans ; Molecular Typing ; methods ; Sequence Analysis, DNA ; methods
10.Vasodilation effect of atropine on rat mesenteric artery.
Jian-pu ZHENG ; Yong-xiao CAO ; Cang-bao XU ; Lars EDVINSSON
Acta Pharmaceutica Sinica 2005;40(5):402-405
AIMTo study the vasodilation effect of atropine and its mechanism.
METHODSIsometric tension was recorded in isolated rat super mesenteric arteries precontracted by noradrenaline (NE) to study the vasodilation effect of atropine, and to investigate the role of endothelial cell and vascular smooth muscle cell on vasodilation.
RESULTSAtropine was shown to significantly dilate the endothelium-intact and endothelium-denuded arteries precontracted by NE. Nomega-Nitro-L-arginine methyl ester (L-NAME, nitric oxide synthase inhabitor), indomethacin (cyclooxygenase inhibitor), propranolol (general beta adrenoceptor antagonist) and glibenclamide (ATP sensitive potassium channel inhibitor) showed no effect on vasodilation of atropine. Atropine did not affect the concentration-contraction curve of K+. However, atropine suppressed the contraction induced by NE and CaCl2, but not that by caffeine in the Ca+ -free Krebs solution.
CONCLUSIONAtropine showed significant vasodilation effect which may derive, in part, from endothelium. Besides, atropine could inhibit the receptor-mediated Ca2+ -influx and Ca2+ -release, which was inferred to the mechanism of atropine on vasodilation.
Animals ; Atropine ; pharmacology ; Calcium ; metabolism ; Calcium Chloride ; antagonists & inhibitors ; Cyclooxygenase Inhibitors ; pharmacology ; Endothelial Cells ; physiology ; Female ; In Vitro Techniques ; Indomethacin ; antagonists & inhibitors ; Male ; Mesenteric Artery, Superior ; drug effects ; NG-Nitroarginine Methyl Ester ; antagonists & inhibitors ; Nitric Oxide Synthase ; antagonists & inhibitors ; Norepinephrine ; antagonists & inhibitors ; Potassium Chloride ; antagonists & inhibitors ; Rats ; Rats, Sprague-Dawley ; Vasodilation ; drug effects ; Vasodilator Agents ; pharmacology